Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report
People with schizophrenia are vulnerable group suffer from metabolic syndrome events. Atypical antipsychotics associated with weight gain, insulin resistance, and profile lipid abnormalities. The present case was 32-year-old man schizophrenia outpatient had experienced metabolic syndrome side effects. Metabolic syndrome characterized by central obesity, hyperglicemia, hypertriglyceridemia, low High Density Lipoprotein (HDL) cholesterol level, and several months feel an increase in appetite. Metabolic syndrome events might be associated with long-term atypical antipsychotics consuming and tobacco use. As pharmacists, We advised the patient to referral primary healthcare service for managing metabolic syndrome side effects. Pharmacists intervention through education and metabolic syndrome screening program have positive impacts on lifestyle modification such as decreasing number of cigarette consumption and caffeine intake, also increasing physical activity.
Keywords: Antipsychotics, Atypical antipsychotic, Metabolic syndrome, Pharmacist, Schizophrenia.
2. World Health Organization. Management of physical health conditions in adult with severe mental disorder. WHO. 2018.
3. Mohamud, WNW, Ismail, AAS, Sharifuddin, A, Ismail, IS, Musa, KI, Kadir, KA, Kamaruddin, NA, Yaacob, NA, Mustafa, N, Ali, O, et al. Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey. Diabetes Res. Clin. Pract, 2011; 91:239–245.
4. De Hert, M, Schreurs, V, Vancampfort, D, Van Winkel, R. Metabolic syndrome in people with schizophrenia: A review. World Psychiatry, 2009; 8:15–22.
5. Von Hausswolff-Juhlin, Y, Bjartveit, M, Lindström, E, Jones, P. Schizophrenia and physical health problems. Acta Psychiatr. Scand, 2009; 119:15–21.
6. Newcomer, J.W. Metabolic syndrome and mental illness. Am. J. Manag. Care, 2007; 13 (Suppl. 7):S170–S177.
7. Panati D, Sudhakar TP, Swetha P, Sayeli VK. A comparative study on metabolic syndrome in patients with schizophrenia treated using first-generation and second-generation antipsychotics. Arch Ment Health, 2020; 21:4-11.
8. Panesar K. Schizophrenia: Managing symptom with antipsychotics, 2012; 37(11):Epub.
9. Julaeha J, Athiyah U, Hermansyah A. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting. Journal of Basic and Clinical Physiology and Pharmacology, 2019; 30(6).
10. Church TJ, Hamer DA, Ulbrich TR. Assessment and management of atypical antipsychotic-induced metabolic abnormalities. US Pharm, 2010; 35(11):41-48.
11. Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatrica Scandinavica, 2015; 132(2):97-108.
12. Yalcin N, Celiker A and Sertac AK. Compliance in schizophrenia spectrum disorder: the role of clinical pharmacist. International Clinical Psychopharmacology, 2019; 34(6):298-304.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).